ZonMw awarded a grant of nearly two million euros to a large group of researchers to improve the outcomes of elderly people with COVID-19. The study, in which the Radboudumc also participates, provides insight into the course and treatment of COVID-19 in the elderly. What is special is that elderly people are explicitly involved in the study.
More than 90% of all deaths from COVID-19 occur in patients aged 70 years and older. Deterioration in daily functioning is common in the elderly as a result of going through COVID-19. In addition, elderly people are very different in terms of vitality and vulnerability. Customized treatment starts with a good estimation of the prognosis and knowledge about the disease, but especially in the elderly there is still much unknown.
Thanks to ZonMw funding for the COVID19 Outcomes in Older People (COOP) study, a research consortium will find answers to important questions about COVID-19 in the elderly, which have been drawn up by the Dutch Medical Specialists Federation in the COVID-19 Knowledge Agenda. The study is led by LUMC, other participating centers are Erasmus MC, Amsterdam UMC and UMC Utrecht.
Role of vulnerability
The COOP study uses Dutch survey data previously collected from more than ten large multicenter studies among older people with COVID-19 at home, and in primary care, hospitals, umbrella centers and nursing homes. Senior epidemiologist René Melis of Radboudumc explains that several questions are central to the study. "We want to know whether frailty can predict the short- and long-term consequences of COVID-19 in the elderly. We also want to develop a model that can be used in healthcare to predict how someone will recover. Another area of research is the role of biological aging and frailty in mortality and recovery. Finally, we are exploring the goals that are important to older people in treatment decisions for acute serious conditions."
Read more about this research on the LUMC website.
Related news items
Most COVID-19 ICU survivors experience symptoms one year after ICU admission Publication in JAMA25 January 2022
75% of the COVID-19 survivors who were treated in the Intensive Care Unit (ICU) experience physical, mental and/or cognitive problems one-year post ICU. This shows the large-scale MONITOR-IC study led by Radboudumc.read more
1.4 million euro to reduce hospital admissions due to medication7 January 2022
A team of sixteen Dutch hospitals received a grant of 1.4 million euros from ZonMw. They will investigate whether they can reduce medication related hospital readmissions.read more
Telemonitoring in chronic heart failure not unqualifiedly positive often additional demand for care without decreasing number of admissions19 October 2021
To contain rising healthcare costs, digitization of healthcare is often seen as a solution. Researchers at the Radboudumc examined the use of telemonitoring in chronic heart failure. Does this reduce hospital admissions and visits to the emergency room?read more
Depressive symptoms during pregnancy affect baby16 September 2021
Depression or depressive symptoms during pregnancy may lead to a bad start for the infant, such as a preterm birth. Researchers of Radboudumc found that this was true for both women who were treated with antidepressants and those who received no medication.read more
Research into treatment for bladder pain syndrome will now be reimbursed4 August 2021
Bladder pain syndrome, also called interstitial cystitis, is a chronic benign condition of the urinary bladderread more